5 Best ADR Stocks To Buy Now
Below we present the list of the 5 Best ADR Stocks To Buy Now.
Posts Tagged ‘NYSE:SNY’
10 Best Vaccine Stocks To Buy Now
One of the most defensive areas of the market is healthcare, and in 2022 when the markets are falling to new lows, healthcare is showing remarkable resilience and even signs of...
15 Most Valuable French Companies in the World
In this article, we will take a look at 15 of the most valuable French companies in the world.
10 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill
In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate's healthcare bill.
Should You Consider Investing in Sanofi (SNY)?
Dodge & Cox Stock Fund, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here.
20 Most Deadliest and Dangerous Snakes In the World
Today we are going to take you for a thrilling virtual tour to the world of the 20 most deadliest and dangerous snakes in the world.
Is SNY A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors ...
Is Sanofi (SNY) Going to Burn These Hedge Funds?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Are Underwhelmed by Sanofi (SNY)’s Growth Prospects
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
3 Stocks Billionaire Warren Buffett Bought in Q3 (and 2 He Dumped)
The latest stock moves made by billionaire investing legend Warren Buffett of Berkshire Hathaway have been revealed through his holding company's 13F filing this week with the...
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Hedge Fund and Insider Trading News: Elliott Management, Ray Dalio, Safety Income & Growth Inc (SAFE), Sanofi SA (SNY), Independent Bank Group Inc (IBTX), and More
On Monday, Sept. 18, The New York Post reported that Elliott Management, Paul Singer's hedge fund, is backing away from its $160-per-share bid for Athenahealth (ATHN).
5 Problematic Stocks Francis Chou Dared To Buy
Francis Chou, a well-regarded Canadian value investor, the founder of Chou Associates Management, and Morningstar Fund Manager of the Decade in 2004, was once just an ordinary...
30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Market Movers Today: Snap Inc (SNAP), Wynn Resorts, Limited (WYNN), Perry Ellis International, Inc. (PERY), and More
What happened: Shares of Snap (NYSE:SNAP) have skyrocketed today, up by 40% as of 12 p.m. EST, after the company reported strong fourth-quarter earnings.
Top 10 Generic Pharmaceutical Companies In 2017
The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries of economic cycles.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Sanofi SA (ADR) (SNY) Hit With Cease And Desist Order On Dengue Vaccine Ads In The Philippines
The Philippines Food and Drug Administration has ordered Sanofi SA (ADR) (NYSE:SNY) to desist from advertising its dengue vaccine or face major consequences.
Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.
Regulator Demands Divestiture In Asset Swap Deal Between Boehringer, Sanofi SA (ADR) (SNY)
Boehringer Ingelheim, a German pharmaceutical firm, are involved in plans to divest of five kinds of products for animal health.
Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims
Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims.
EMA Reviews Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY) Dupixent MAA
The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (...
Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)
Sanofi SA (ADR) (NYSE:SNY) could spark a fierce bidding war for Actelion Ltd (OTCMKTS:ALIOF).
Is Sanofi SA (ADR) (SNY) a Good Stock To Buy?
Is Sanofi SA (ADR) (NYSE:SNY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters
Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s blockbuster drug, dupilumab, according...
US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6
The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...
Sanofi SA (ADR) (SNY) Can Thank Its Vaccines
Sanofi SA (ADR) (NYSE:SNY) Pasteur seems to be making it big with its vaccines. In the third quarter the French drugmaker’s sales grew by 14% over last year.
Hedge Fund Managers Discuss Shorting Viasat (VSAT), 2U (TWOU), Long Positions in Microsoft (MSFT), Others
Large hedge funds are required to disclose all of their long stakes in U.S.-traded securities once per quarter.
Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...
FDA’s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi
We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)’s insulin combo candidate IGlarLixi.
Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?
It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve it.
The Most Popular French Stocks Among Hedge Funds
French president François Hollande was recently quoted as saying “ça va mieux” of his country's economy, which means that things are improving.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Why Sanofi SA (ADR) (SNY) Is Trending on Wednesday
Sanofi SA (ADR) (NYSE:SNY) is preparing to oust all the board members of Medivation, Reuters reported on Wednesday, citing people familiar with the matter.
Warren Buffett’s Best High-Yield Dividend Stocks – May 2016 Update
Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...
Why These Five Stocks Are Trending Today?
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus 200,000 expected.
Why These Five Stocks Are on the Move Today?
Markets are trading lower on Friday following the recent sell-off in several tech stocks amid the earnings season.
Why Investors Are Buzzing About These Stocks Today
It's M&A Thursday, as several major M&A deals have been announced today.
Warren Buffett’s Best High-Yield Dividend Stocks
Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...
Here is What Hedge Funds Think About Sanofi SA (ADR) (SNY)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Billionaire Ken Fisher’s Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus
In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to...
